Market Overview

SpringWorks Opens Above IPO Price


Springworks Therapeutics, Inc. (NASDAQ: SWTX) made its public debut Friday morning, opening at $24.50 after being priced between $16 and $18 per share.

The company's shares have been listed on the Nasdaq under the ticker symbol "SWTX."

Invest in IPO shares before the stock hits the market with ClickIPO. Check it out here

Springworks Therapeutics IPO: What You Need To Know

Springworks, founded in August 2017, is a clinical-stage biopharma company applying a precision medicine approach to develop medicines for rare diseases and cancer. It has a differentiated portfolio of small molecule targeted oncology product candidates.

JPMorgan, Goldman Sachs, Cowen and Wedbush PacGrow are the underwriters for the offering.

Posted-In: News IPOs


Related Articles (SWTX)

View Comments and Join the Discussion!

How To Make The Most Of Your Staycation

Exclusive: Canopy Growth Co-Founder Bruce Linton On His Next Steps, Says 'I'm Cheering For Entrepreneurs'